Epilepsy Program

Clinical Trials & Research

The Stanford Epilepsy Center constantly seeks to develop better therapies for seizure disorders.  Our research program changes frequently. Experimental studies listed below are in progress.  Referral of potential patients for experimental protocols should be via your physician.

  1. Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy - SANTE, testing the Medtronic Intercept Device. Robert Fisher, M.D., Ph.D. National Principle Investigator.  This study investigates whether electrodes surgically implanted into the thalamus, a pacemaker nucleus deep in brain, can improve previously unresponsive seizures.

  2. Early Randomized Surgical Treatment for Epilepsy (ERSET), sponsored by NIH, Michael Risinger, M.D., Center Principle Investigator.  This study investigated the best time in the course of epilepsy to consider brain surgery for the epilepsy.

  3. Talampanel for Refractory Partial Seizures, sponsored by Ivax Pharmaceuticals, Dr. Michael Risinger, Center Principle Investigator.  This is a study of a new drug for epilepsy, based upon block of an excitatory neurotransmitter in the brain.

  4. Diagnosis and Therapy of Nonepileptic Seizures. John Barry, M.D., Principle Investigator. This research studies the best way for diagnosing and treating non-epileptic seizures, which are seizure-like events manifesting from psychological causes.

Extensive research is performed on the basic mechanisms of epilepsy, in the laboratories of Dr. David Prince, John Huguenard and Paul Buckmaster, and associates. 

This research links to the Neurosciences, Biology and Molecular Biology programs at Stanford, which are among the strongest in the world.

Stanford Medicine Resources:

Footer Links: